These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36252711)

  • 1. The Effects of Human Papillomavirus Infection and Vaccination on Cardiovascular Diseases, NHANES 2003-2016.
    Liang X; Chou OHI; Cheung BMY
    Am J Med; 2023 Mar; 136(3):294-301.e2. PubMed ID: 36252711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis.
    Closson K; Karim ME; Sadarangani M; Naus M; Ogilvie GS; Donken R
    Vaccine; 2020 Dec; 38(52):8396-8404. PubMed ID: 33239227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates Among US Adult Men: National Health and Nutrition Examination Survey (NHANES) 2013-2014.
    Han JJ; Beltran TH; Song JW; Klaric J; Choi YS
    JAMA Oncol; 2017 Jun; 3(6):810-816. PubMed ID: 28114440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years).
    Guo F; Hirth JM; Berenson AB
    Hum Vaccin Immunother; 2015; 11(10):2337-44. PubMed ID: 26376014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Human Papillomavirus Types 16/18 and Effect of Vaccination among Japanese Female General Citizens in the Vaccine Crisis Era.
    Kitamura T; Suzuki M; Shigehara K; Fukuda K; Matsuyama T; Kume H
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States.
    Chaturvedi AK; Graubard BI; Broutian T; Pickard RKL; Tong ZY; Xiao W; Kahle L; Gillison ML
    J Clin Oncol; 2018 Jan; 36(3):262-267. PubMed ID: 29182497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.
    Chandler E; Ding L; Gorbach P; Franco EL; Brown DA; Widdice LE; Bernstein DI; Kahn JA
    J Adolesc Health; 2018 Jul; 63(1):43-49. PubMed ID: 30060856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
    J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling.
    Deleré Y; Remschmidt C; Leuschner J; Schuster M; Fesenfeld M; Schneider A; Wichmann O; Kaufmann AM
    BMC Infect Dis; 2014 Feb; 14():87. PubMed ID: 24552260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
    Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F
    Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction.
    Covert C; Ding L; Brown D; Franco EL; Bernstein DI; Kahn JA
    Hum Vaccin Immunother; 2019; 15(7-8):1962-1969. PubMed ID: 30633598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016-2019.
    Sheth SS; Johnson NP; Sullivan EL; Torres AR; Oliveira CR; Niccolai LM
    J Womens Health (Larchmt); 2024 Jan; 33(1):28-32. PubMed ID: 37943625
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
    Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
    BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014).
    Hirth JM; Kuo YF; Starkey JM; Rupp RE; Laz TH; Rahman M; Berenson AB
    Vaccine; 2019 Jul; 37(30):4040-4046. PubMed ID: 31182324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the Affordable Care Act dependent coverage provision on HPV vaccine uptake in young adult women, National Health and Nutrition Examination Survey 2007-2016.
    Raymond S; Li L; Taioli E; Nash D; Liu B
    Prev Med; 2021 Jul; 148():106536. PubMed ID: 33798531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of Human Papillomavirus Vaccination and Association with HPV-16 and HPV-18 DNA Detection in Young Women.
    Feder MA; Kulasingam SL; Kiviat NB; Mao C; Nelson EJ; Winer RL; Whitham HK; Lin J; Hawes SE
    J Womens Health (Larchmt); 2019 Oct; 28(10):1428-1435. PubMed ID: 31264912
    [No Abstract]   [Full Text] [Related]  

  • 17. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.
    Chow EP; Danielewski JA; Fehler G; Tabrizi SN; Law MG; Bradshaw CS; Garland SM; Chen MY; Fairley CK
    Lancet Infect Dis; 2015 Nov; 15(11):1314-23. PubMed ID: 26201300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccination and cervical cytology in young minority women.
    Brogly SB; Perkins RB; Zepf D; Longtine J; Yang S
    Sex Transm Dis; 2014 Aug; 41(8):511-4. PubMed ID: 25013981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in Vaccine HPV Type Infections in a Young Women Group (18-25 Years) Five Years after HPV Vaccine Introduction in Colombia.
    Combita AL; Reyes V; Puerto D; Murillo R; Sánchez R; Nuñez M; Hernandez-Suarez GA; Wiesner C
    Cancer Prev Res (Phila); 2022 Jan; 15(1):55-66. PubMed ID: 34610993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between bacterial vaginosis with human papillomavirus in the United States (NHANES 2003-2004).
    Qi J; Dai C; Song L; Zhang J
    BMC Womens Health; 2024 Feb; 24(1):138. PubMed ID: 38388384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.